Anbu Kochi joins hands with PULSUS Group in support of Kerala Flood Victims

In a humanitarian effort, PULSUS Group - in collaboration with Anbu Kochi - is responding to the calamity of the recent, unprecedented floods in the Indian state of Kerala by providing contributions to aid relief and rehabilitation measures. PULSUS Group took initiative to extend a helping hand in donating clothes, food items, medicines, sanitation, hygiene products including edibles (baby food, ORS packets/electrolytes, rusk, biscuits), and non-edibles (anti-septic lotion, bleaching powder/lime powder, baby diapers, adult diapers, sanitary napkins, toothpaste, tooth brushes, body soap, washing soap, clothes old/new, water cans, candles and match boxes). PULSUS Group and Anbu Kochi are collecting daily essentials and other relief materials to help Kerala flood victims. PULSUS Group and Anbu Kochi stand for Kerala in helping the flood victims with necessities and donations.

In addition, all the employees at PULSUS Group have generously raised funds for the cause. Dr. Srinubabu Gedela, CEO, Pulsus & Omics International, addressing the issue has said, "What Kerala has experienced today is unparalleled by any of the disasters that the state had suffered in recent times. We take social responsibility to stand by them. Rebuilding the state can take years to come. Every rupee and contribution donated goes towards the wellbeing and uplifting of the state. Our thoughts and prayers are with flood relief victims, displaced, homeless families and the needs of the hour require our call of action to address their immediate needs to provide shelter, livelihood, and non-food items."

About PULSUS Group: PULSUS Group is an internationally renowned peer-review publisher and conferences organizer operational since 1984. Headquartered at Singapore, PULSUS Group has its offices in London (UK), Ontario (Canada) and Chennai, Gurgaon, Hyderabad (India). Endorsed by the medical associations and scientific societies, PULSUS promotes peer reviewed medical journals in association with international medical associations and scientific societies. PULSUS organizes 500+ global meetings per year across the world, enables physicians and industry professionals to convene together and form conclusive strategies towards advanced therapeutics and treatment aspects. PULSUS Group strives to reach out to broad range of target groups and market leaders across diverse spectrum of research fields, providing high quality information across USA, Europe, Asia Pacific and ME.

- Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections
- The first combination of a carbapenem and a beta-lactamase inhibitor approved for clinical use in...

- Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics
- Cloud-based in silico platform that screens small molecules to determine polypharmacological profiles
- Evaluation to include...